Metastatic Carcinoid Tumors
Also known as: Metastatic carcinoid tumour / Metastatic Carcinoid Tumor / Metastatic carcinoid tumor (morphologic abnormality) / Metastatic carcinoid tumor (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00104 | Octreotide | A peptide drug used to treat acromegaly as well as diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide secreting tumors. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00104 | Octreotide | Myeloperoxidase | enzyme |
DB00104 | Octreotide | Cytochrome P450 3A4 | enzyme |
DB00104 | Octreotide | Somatostatin receptor | target |
DB00104 | Octreotide | Serum albumin | carrier |
DB00104 | Octreotide | P-glycoprotein 1 | transporter |
DB00104 | Octreotide | Canalicular multispecific organic anion transporter 1 | transporter |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01101 | Capecitabine | 1 | Withdrawn | 1 |
DB00853 | Temozolomide | 1 | Withdrawn | 1 |
DB07232 | Veliparib | 1 | Withdrawn | 1 |
DB09079 | Nintedanib | 2 | Completed | 1 |
DB00135 | Tyrosine | 2 | Completed | 1 |